MbrlCatalogueTitleDetail

Do you wish to reserve the book?
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
Hey, we have placed the reservation for you!
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Title added to your shelf!
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
How would you like to get it?
We have requested the book for you! Sorry the robot delivery is not available at the moment
We have requested the book for you!
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
Journal Article

Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes

2012
Request Book From Autostore and Choose the Collection Method
Overview
Pancreatic cancer is a highly lethal malignancy with few effective therapies. We performed exome sequencing and copy number analysis to define genomic aberrations in a prospectively accrued clinical cohort ( n = 142) of early (stage I and II) sporadic pancreatic ductal adenocarcinoma. Detailed analysis of 99 informative tumours identified substantial heterogeneity with 2,016 non-silent mutations and 1,628 copy-number variations. We define 16 significantly mutated genes, reaffirming known mutations ( KRAS , TP53 , CDKN2A, SMAD4 , MLL3 , TGFBR2, ARID1A and SF3B1 ), and uncover novel mutated genes including additional genes involved in chromatin modification ( EPC1 and ARID2 ), DNA damage repair ( ATM ) and other mechanisms ( ZIM2 , MAP2K4 , NALCN , SLC16A4 and MAGEA6 ). Integrative analysis with in vitro functional data and animal models provided supportive evidence for potential roles for these genetic aberrations in carcinogenesis. Pathway-based analysis of recurrently mutated genes recapitulated clustering in core signalling pathways in pancreatic ductal adenocarcinoma, and identified new mutated genes in each pathway. We also identified frequent and diverse somatic aberrations in genes described traditionally as embryonic regulators of axon guidance, particularly SLIT/ROBO signalling, which was also evident in murine Sleeping Beauty transposon-mediated somatic mutagenesis models of pancreatic cancer, providing further supportive evidence for the potential involvement of axon guidance genes in pancreatic carcinogenesis. Exome sequencing and copy number analysis are used to define genomic aberrations in early sporadic pancreatic ductal adenocarcinoma; among the findings are mutations in genes involved in chromatin modification and DNA damage repair, and frequent and diverse somatic aberrations in genes known as embryonic regulators of axon guidance. New mutations identified in pancreatic cancer This large-scale study presents exome sequencing and copy number variant analysis from 142 patients with pancreatic ductal adenocarcinoma, the most common form of pancreatic cancer. Among the findings are mutations in genes involved in chromatin modification and DNA damage repair, not previously implicated in this disease. Importantly, the data show that abnormal expression of genes involved in slit and semaphorin signalling is associated with poor patient survival, and in animal models was associated with disease development and progression.